Publications by authors named "George Laws"

Article Synopsis
  • Early risk assessment of drug-induced liver injury (DILI) is crucial in pharmaceutical development, and researchers have created rat liver biomarkers to predict the potential for high-risk reactive metabolites.
  • A new in vitro assay using advanced micropatterned coculture (HEPATOPAC) with rat hepatocytes has been developed to identify drugs with lower DILI risk, achieving 81% sensitivity and 90% specificity for detecting hepatotoxicants.
  • This approach allows for early drug discovery screening, guiding the selection of safer drug candidates while utilizing rat models routinely and human models when needed.
View Article and Find Full Text PDF

A novel class of human β(3)-adrenergic receptor agonists was designed in effort to improve selectivity and metabolic stability versus previous disclosed β(3)-AR agonists. As observed, many of the β(3)-AR agonists seem to need the acyclic ethanolamine core for agonist activity. We have synthesized derivatives that constrained this moiety by introduction of a pyrrolidine.

View Article and Find Full Text PDF

3-Methylindole (3MI), melatonin (Mel), serotonin (Ser), and tryptamine (Tryp) were evaluated in vitro for their potential to induce DNA adducts, DNA strand breaks, chromosomal aberrations (Abs), inhibition of DNA synthesis, and mutations. All compounds produced DNA adducts in calf thymus DNA in the presence of rat liver S9. In cultured rat hepatocytes, all produced DNA adducts but none induced DNA strand breaks.

View Article and Find Full Text PDF